SEC Form 4
Treace Medical Concepts, Inc. (TMCI) insider trading
In the 12 months to Nov 17, 2026, one TMCI insider reported open-market purchases of $1.2M across 5 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $1.2M
- 5 filings · John T. Treace, Chief Executive Officer
Who traded TMCI, and when
- Purchase
TMCI daily close from Nov 17, 2025 to Nov 16, 2026, between $1.20 and $5.34, last $4.42. 0 sale and 5 purchase filings by 1 insider, marked at their filing dates. John T. Treace, Chief Executive Officer: bought $1.2M across 5 filings, first filed May 14, 2026, last Aug 24, 2026.
Largest mark · tap a row for others
John T. Treace · Chief Executive Officer
Filing 1 of 2 within a week · $518,504 total
Purchase $340,589
115,520 shares at $2.95 avg
Filed May 28, 2026 · traded May 26
Close on filing date $3.08
John T. Treace · Chief Executive Officer
Chief Executive Officer
$1.2M boughtOpen-market trades
5 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| John T. Treace | Chief Executive Officer | — | $1.2M | 5 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | John T. Treace Chief Executive Officer | Purchase | 55,944 | $4.41 | $246.7K | 7,404,383 | |
traded | John T. Treace Chief Executive Officer | Purchase | 24,606 | $4.03 | $99.2K | 7,348,439 | |
traded | John T. Treace Chief Executive Officer | Purchase | 50,000 | $3.56 | $177.9K | 7,323,833 | |
traded | John T. Treace Chief Executive Officer | Purchase | 115,520 | $2.95 | $340.6K | 7,273,833 | |
traded | John T. Treace Chief Executive Officer | Purchase | 153,763 | $2.44 | $375.5K | 7,158,313 |
GET /stocks/filings/vX/form-4?tickers=TMCI&filing_date.gte=2025-11-17&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"TMCI"
],
"issuer_cik": "0001630627",
"owner_cik": "0001856380",
"accession_number": "0001193125-26-363737",
"form_type": "4",
"filing_date": "2026-08-24",
"period_of_report": "2026-08-20",
"issuer_name": "TREACE MEDICAL CONCEPTS, INC.",
"issuer_trading_symbol": "TMCI",
"owner_name": "Treace John T.",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-20",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 39944,
"transaction_price_per_share": 4.4356,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 7388383,
"transaction_value": 177175.6064,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3198 to $4.5048 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "Includes 542,784 restricted stock units."
}
]
},
{
"tickers": [
"TMCI"
],
"issuer_cik": "0001630627",
"owner_cik": "0001856380",
"accession_number": "0001193125-26-363737",
"form_type": "4",
"filing_date": "2026-08-24",
"period_of_report": "2026-08-20",
"issuer_name": "TREACE MEDICAL CONCEPTS, INC.",
"issuer_trading_symbol": "TMCI",
"owner_name": "Treace John T.",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-21",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 4.3495,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 7393383,
"transaction_value": 21747.5,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Includes 542,784 restricted stock units."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 36 records
- Option exercises2 records
- Tax withholding22 records
- Grants and awards12 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Treace Medical Concepts, Inc.'s CEO sold stock?
No. John T. Treace (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is TMCI’s insider data?
These are TMCI Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track TMCI insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for TMCI every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.